NCT03061851Unknown不适用
A Multicenter, Prospective, Randomized, Controlled Clinical Trial of the Individualized Behavioral Intervention of Smartphone App in the Treatment of Type 2 Diabetes Mellitus
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 400
- 试验地点
- 1
- 主要终点
- The proportion of patients with HbA1c <7% after 48 weeks of maltose software intervention
研究概览
简要总结
The patients with type 2 diabetes who underwent routine hypoglycemic agents and insulin therapy were evaluated for 48 weeks with maltose software.
详细描述
This study enrolled 400 patients with type 2 diabetes in five centers in Shandong Province, China. Patients with type 2 diabetes who met the inclusion / exclusion criteria were randomly assigned to the trial group (conventional treatment + maltose app) or the control group (conventional treatment) in a 1: 1 ratio.
The control group: given conventional hypoglycemic drug treatment, the treatment plan by the investigators according to the patient's condition may be, this study does not interfere.
The trial group: the patients were treated with conventional hypoglycemic drugs. The treatment plan was decided by the researcher according to the patient's condition. The intervention was not done in this study.
Interventions include:
- Weekly diabetes-related science articles.
- Patients reported hypoglycemia or other adverse reactions, the competent physician to deal with.
- Questionnaires published out the hospital (2 weeks 1), the feedback for the problem.
- monitoring of abnormal blood glucose data or the presence of related discomfort, can communicate with the competent physician online.
- Personalize the development of diet, exercise program.
- different insulin and oral hypoglycemic drug medication time to remind.
- hypoglycemic drug side effects query.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male and female patients diagnosed with type 2 diabetes, age ≥ 18 years and ≤ 65 years;
- •diagnosis of type 2 diabetes ≥6 months;
- •The patient signed an informed consent form and agreed to collect the data. The trial group agreed to apply the maltose app during the trial period to study popular science articles, to receive software reminders and to answer questions regularly;
- •HbA1c≥7.0% in the last one (≤3 months) before enrollment;
- •be able to use Mobile App;
- •The mobile phone used by the patient must support maltose App installation.
- •Receiving regular diabetes education in the hospital.
排除标准
- •Has participated in any randomized controlled clinical study;
- •To long-term use of insulin pump as the main treatment of type 2 diabetes;
- •patients with type 1 diabetes;
- •pregnant or lactating women;
- •doctor, alcohol, drug abuse, schizophrenia, severe vision and hearing impaired;
- •Can not accept software manager;
- •Other investigators considered it inappropriate to participate in the study.
结局指标
主要结局
The proportion of patients with HbA1c <7% after 48 weeks of maltose software intervention
时间窗: 48 weeks
次要结局
- The changes of HbA1c at baseline, 48 weeks, 36 weeks, 24 weeks and 12 weeks after intervention were compared.(48 weeks, 36 weeks, 24 weeks and 12 weeks.)
- The changes of FPG and 2hPG, blood lipids and uric acid in the 48 weeks and 24 weeks after the intervention were compared.(48 weeks and 24 weeks)
- The proportion of the different subgroups patients(baseline BMI<24kg/m2, ≥24kg/m2 and ≤28kg/m2 and >28kg/m2; baseline HbA1c≤8%,>8% and ≤10% and >10%) with HbA1c<7% after 48 weeks and 24 weeks of intervention(48 weeks and 24 weeks)
- The changes of body weight, waist circumference and hip circumference were compared with baseline at 48 weeks, 36 weeks, 24 weeks and 12 weeks after the intervention.(48 weeks, 36 weeks, 24 weeks and 12 weeks)
- The total score of the Morisky compliance questionnaire at baseline, 48 weeks, 36 weeks, 24 weeks, and 12 weeks after intervention was compared with baseline.(48 weeks, 36 weeks, 24 weeks, and 12 weeks)
- The total score of self - rating anxiety scale at 48 weeks after intervention was higher than baseline.(48 weeks)
- The scores of self - management behavior of patients with diabetes at baseline, 48 weeks, 36 weeks, 24 weeks and 12 weeks after intervention were compared.(48 weeks, 36 weeks, 24 weeks and 12 weeks)
- The total score of Kessler's psychological distress scale after 48 weeks of intervention was higher than baseline.(48 weeks)
研究者
研究点 (1)
Loading locations...
相似试验
终止
4 期
Type 2 Diabetes Management With Lantus® (Malbec: Manejo Con Lantus® de Diabéticos Tipo 2)Type 2 DiabetesNCT00627471Sanofi9
已完成
3 期
Study Evaluating Rimonabant Efficacy in Insulin-Treated Diabetic Patients(ARPEGGIO)Type 2 Diabetes MellitusNCT00288236Sanofi368
已完成
2 期
A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 DiabetesDiabetes Mellitus, Type 2NCT02053272Jazz Pharmaceuticals207
Unknown
4 期
Triple Therapy in Type 2 Diabetic PatientsType 2 Diabetes MellitusNCT01895569University of Pavia64
已完成
2 期
Exploratory Study to Access the Metabolic Effects of Ranolazine in Subjects With Type 2 Diabetes Mellitus When Added to Ongoing Non-insulin Antidiabetic TherapyDiabetes Mellitus, Type 2NCT01163721Gilead Sciences80